Affirm (AFRM) director sells 2,000 shares under Rule 10b5-1 plan

Rhea-AI Filing Summary

Affirm Holdings, Inc. director Noel Bertram Watson reported an open-market sale of 2,000 shares of Class A Common Stock at $55.00 per share on April 14, 2026. After this transaction, he directly holds 38,076 shares.

The filing notes that the sale was carried out under a pre-arranged Rule 10b5-1 trading plan adopted by the reporting person, indicating the trade was scheduled in advance rather than timed discretionarily.

Insider Trade Summary 10b5-1

Net Seller: 2,000 shares ($110,000)

Net Sell 1 txn

Insider Watson Noel Bertram

Role Director

Sold 2,000 shs ($110K)

Type	Security	Shares	Price	Value
Sale	Class A Common Stock	2,000	$55.00	$110K

Holdings After Transaction: Class A Common Stock — 38,076 shares (Direct)

Footnotes (1)

1. [object Object]

Key Figures

Shares sold: 2,000 shares Sale price: $55.00 per share Shares held after transaction: 38,076 shares +2 more

5 metrics

Shares sold 2,000 shares Open-market sale on April 14, 2026

Sale price $55.00 per share Class A Common Stock transaction

Shares held after transaction 38,076 shares Direct ownership following sale

Net share change -2,000 shares Net-sell direction in transaction summary

Sell transactions count 1 transaction Single non-derivative open-market sale

Key Terms

Class A Common Stock, open-market sale, Rule 10b5-1 trading plan, Form 4

4 terms

Class A Common Stock financial

"security_title: "Class A Common Stock""

Class A common stock is a category of a company’s shares that carries a specific set of ownership rights—most commonly defined voting power and claims on dividends—set out in the company’s charter. For investors it matters because the class determines how much influence you have over corporate decisions, the share’s likely dividend and trading behavior, and how it compares in value to other share classes, like choosing a particular seat with different privileges at the company’s decision-making table.

open-market sale financial

"transaction_action: "open-market sale""

An open-market sale is when a shareholder sells existing shares directly on a public exchange to any willing buyer, rather than through a private deal. Think of it like putting goods on a busy market stall where price is set by supply and demand; for investors it matters because such sales increase available supply, can put short-term downward pressure on the stock price, and signal changes in liquidity or investor confidence.

Rule 10b5-1 trading plan regulatory

"The sales reported ... were effected pursuant to a Rule 10b5-1 trading plan"

A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.

Form 4 regulatory

"The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Watson Noel Bertram

(Last) (First) (Middle)

C/O AFFIRM HOLDINGS, INC.

650 CALIFORNIA STREET

(Street)

SAN FRANCISCO CALIFORNIA 94108

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Affirm Holdings, Inc. [ AFRM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/14/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	04/14/2026		S		2,000(1)	D	$55	38,076	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 2, 2025.

Remarks:

	/s/ Josh Samples, Attorney-in-Fact	04/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did Affirm (AFRM) director Noel Bertram Watson report?

Noel Bertram Watson reported selling 2,000 shares of Affirm Class A Common Stock. The shares were sold in an open-market transaction at $55.00 per share, and the trade was executed under a pre-arranged Rule 10b5-1 trading plan.

How many Affirm (AFRM) shares does Noel Bertram Watson hold after this Form 4?

After the reported sale, Noel Bertram Watson directly holds 38,076 shares of Affirm Class A Common Stock. This reflects his remaining position following the 2,000-share open-market sale disclosed in the Form 4 filing for the April 14, 2026 transaction.

Was the Affirm (AFRM) insider sale by Noel Bertram Watson pre-planned?

Yes. The filing states that the sale was effected under a Rule 10b5-1 trading plan adopted by Noel Bertram Watson. Such plans pre-schedule trades, meaning the timing of this 2,000-share sale at $55.00 was determined in advance rather than chosen opportunistically.

What price did Noel Bertram Watson receive for the Affirm (AFRM) shares sold?

The Form 4 shows that Noel Bertram Watson’s 2,000 shares of Affirm Class A Common Stock were sold at an average price of $55.00 per share. This price applies to the entire block of shares reported in the single open-market transaction on April 14, 2026.

Does this Affirm (AFRM) Form 4 show any option exercises or derivative trades?

No. The Form 4 only reports a non-derivative transaction: an open-market sale of 2,000 shares of Class A Common Stock. The derivativeSummary section is empty, indicating there were no option exercises or other derivative security transactions disclosed in this filing.